483 Gemini Pharmaceuticals Feb 2018

483 Gemini Pharmaceuticals Feb 2018

Christopher Fields FDA, Jose Hernandez FDA$119.00 - Available Now

FDA investigators audited the Gemini Pharmaceuticals - Commack, NY, United States facility and issued inspectional observations (via FDA 483) on 16 Feb 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Feb 2018
  • Location: Commack, United States
  • FEI: 2432926
Add To Cart